Student Zoe Davis, 20, was just weeks into her junior year when she landed back in the hospital with severe sickle cell pain ...
After Pfizer withdrew its sickle cell drug from the market, patients with the condition and their doctors were left ...
Pfizer Inc. said late Wednesday it was withdrawing a sickle-cell drug from markets worldwide and discontinuing clinical ...
Pfizer's decision late on Wednesday to withdraw its sickle cell disease treatment due to the risk of death could help speed ...
A man and woman, both with sickle cell, share what their experience was like finding love, and what prospective partners need ...
U.S. drugmaker Pfizer said on Wednesday it was withdrawing its sickle cell disease treatment Oxbryta from all markets where ...
September is Sickle Cell Awareness month.While the month itself is almost over, patients living with the disease face a daily ...
Pfizer’s decision Wednesday to pull its sickle cell pill off the market because of safety concerns shocked advocates and ...
Pfizer had big hopes for a sickle-cell disease drug, as did those suffering from the disease. Things didn't turn out as ...
The healthcare company said clinical data indicates the overall benefit of Oxbryta no longer outweighs the risk in the ...
The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...
Officials hosted a tour Friday and launched a groundbreaking pediatric treatment for sickle cell disease. Yunigen officials, including Chief Executive Officer and Vice President Charles Otieno and ...